Boiron SA (LON:0DTF)

Market Cap	359.72M
Revenue (ttm)	403.20M
Net Income (ttm)	9.37M
Shares Out	n/a
EPS (ttm)	0.54
PE Ratio	38.37
Forward PE	15.65
Dividend	1.15 (4.69%)
Ex-Dividend Date	Jun 3, 2025

Volume	n/a
Average Volume	10
Open	24.45
Previous Close	24.75
Day's Range	24.45 - 24.45
52-Week Range	23.55 - 36.30
Beta	0.48
RSI	48.09
Earnings Date	Apr 22, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DTF

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial numbers in EUR